ArticleClinical drug investigation2020

Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.

Katherine A Lyseng-WilliamsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.